Moebius Syndrome Market Research Information: By Type (Group I, Group Ii, Group Iii, Group Iv), Treatment (Surgery, Parotidectomy, Temporalis Transfer, Speech & Occupational Therapy, Prosthesis, Splints, and Braces), End User – Global Forecast till 2027
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Moebius Syndrome Market, by Type
6.1 Introduction
6.2 Group I
6.2.1 Market Estimates & Forecast, 2020 – 2027
6.3 Group II
6.3.1 Market Estimates & Forecast, 2020 – 2027
6.4 Group III
6.4.1 Market Estimates & Forecast, 2020 – 2027
6.5 Group IV
6.5.1 Market Estimates & Forecast, 2020 – 2027
Chapter 7. Global Moebius Syndrome Market, by Type of Treatment
7.1 Introduction
7.2 Surgery
7.2.1 Market Estimates & Forecast, 2020 – 2027
7.3 Temporalis Transfer
7.3.1 Market Estimates & Forecast, 2020 – 2027
7.4 Parotidectomy
7.4.1 Market Estimates & Forecast, 2020 – 2027
7.5 Physical Therapy
7.5.1 Market Estimates & Forecast, 2020 – 2027
7.6 Occupational Therapy
7.6.1 Market Estimates & Forecast, 2020 – 2027
7.7 Speech Therapy
7.7.1 Market Estimates & Forecast, 2020 – 2027
7.8 Splints
7.8.1 Market Estimates & Forecast, 2020 – 2027
7.9 Prosthesis
7.9.1 Market Estimates & Forecast, 2020 – 2027
7.10 Braces
7.10.1 Market Estimates & Forecast, 2020 – 2027
7.11 Others
7.11.1 Market Estimates & Forecast, 2020 – 2027
Chapter 8. Global Moebius Syndrome Market, by End User
8.1 Introduction
8.2 Medical Device Companies
8.2.1 Market Estimates & Forecast, 2020 – 2027
8.3 Hospitals & Clinics
8.3.1 Market Estimates & Forecast, 2020 – 2027
8.4 Academic & Research Institutes
8.4.1 Market Estimates & Forecast, 2020 – 2027
8.5 Others
8.5.1 Market Estimates & Forecast, 2020 – 2027
Chapter 9. Global Moebius Syndrome Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 U.K
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of the Middle East & Africa
Chapter 10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Alcon Laboratories, Inc
11.1.1 Company Overview
11.1.2 Type of Causative Agents Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 All Vascular, Pty Ltd.
11.2.1 Company Overview
11.2.2 Type of Causative Agents Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Aspen Surgical Products, Inc.
11.3.1 Company Overview
11.3.2 Type of Causative Agents Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 B. Braun Melsungen AG
11.4.1 Company Overview
11.4.2 Type of Causative Agents/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Boston Scientific Corporation
11.5.1 Company Overview
11.5.2 Type of Causative Agents Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.6 BECTON, DICKINSON AND COMPANY
11.6.1 Company Overview
11.6.2 Type of Causative Agents Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 Johnson & Johnson Services, Inc.
11.7.1 Overview
11.7.2 Type of Causative Agents Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Moebius Syndrome Industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Moebius Syndrome Industry Synopsis, 2020 – 2027
Table 2 Moebius Syndrome Market Estimates and Forecast, 2020 – 2027, (USD Million)
Table 3 Moebius Syndrome Market by Region, 2020 – 2027, (USD Million)
Table 4 Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)
Table 5 Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)
Table 6 Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)
Table 7 North America Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)
Table 8 North America Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)
Table 9 North America Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)
Table 10 US Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)
Table 11 US Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)
Table 12 US Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)
Table 13 Canada Moebius Syndrome market by Type, 2020 – 2027, (USD Million)
Table 14 Canada Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)
Table 15 Canada Moebius Syndrome market by End Users, 2020 – 2027, (USD Million)
Table 16 South America Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)
Table 17 South America Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)
Table 18 South America Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)
Table 19 Europe Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)
Table 20 Europe Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)
Table 21 Europe Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)
Table 22 Western Europe Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)
Table 23 Western Europe Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)
Table 24 Western Europe Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)
Table 25 Eastern Europe Moebius Syndrome market by Type, 2020 – 2027, (USD Million)
Table 26 Eastern Europe Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)
Table 27 Eastern Europe Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)
Table 28 Asia Pacific Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)
Table 29 Asia Pacific Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)
Table 30 Asia Pacific Moebius Syndrome market by End Users, 2020 – 2027, (USD Million)
Table 31 The Middle East & Africa Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)
Table 32 The Middle East & Africa Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)
Table 33 The Middle East & Africa Moebius Syndrome market by End Users, 2020 – 2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Moebius Syndrome Market
Figure 3 Segmentation Market Dynamics for Moebius Syndrome Market
Figure 4 Global Moebius Syndrome market Share, by Type 2020
Figure 5 Global Moebius Syndrome market Share, by Type of Treatment 2020
Figure 6 Global Moebius Syndrome market Share, by End Users, 2020
Figure 7 Global Moebius Syndrome market Share, by Region, 2020
Figure 8 North America Moebius Syndrome market Share, by Country, 2020
Figure 9 Europe Moebius Syndrome market Share, by Country, 2020
Figure 10 Asia Pacific Moebius Syndrome market Share, by Country, 2020
Figure 11 Middle East & Africa Moebius Syndrome market Share, by Country, 2020
Figure 12 Global Moebius Syndrome market: Company Share Analysis, 2020 (%)
Figure 13 Alcon Laboratories, Inc: Key Financials
Figure 14 Alcon Laboratories, Inc: Segmental Revenue
Figure 15 Alcon Laboratories, Inc: Geographical Revenue
Figure 16 All Vascular, Pty Ltd.: Key Financials
Figure 17 All Vascular, Pty Ltd.: Segmental Revenue
Figure 18 All Vascular, Pty Ltd.: Geographical Revenue
Figure 19 Aspen Surgical Products, Inc.: Key Financials
Figure 20 Aspen Surgical Products, Inc.: Segmental Revenue
Figure 21 Aspen Surgical Products, Inc.: Geographical Revenue
Figure 22 B. Braun Melsungen AG : Key Financials
Figure 23 B. Braun Melsungen AG : Segmental Revenue
Figure 24 B. Braun Melsungen AG : Geographical Revenue
Figure 25 Boston Scientific Corporation: Key Financials
Figure 26 Boston Scientific Corporation: Segmental Revenue
Figure 27 Boston Scientific Corporation Geographical Revenue
Figure 28 BECTON, DICKINSON AND COMPANY: Key Financials
Figure 29 BECTON, DICKINSON AND COMPANY: Segmental Revenue
Figure 30 BECTON, DICKINSON AND COMPANY: Geographical Revenue
Figure 31 Johnson & Johnson Services, Inc.: Key Financials
Figure 32 Johnson & Johnson Services, Inc.: Segmental Revenue
Figure 33 Johnson & Johnson Services, Inc.: Geographical Revenu
Speak to Analyst
Request a Free Sample
Moebius Syndrome Market Scenario
Moebius syndrome is a rare neurological condition characterized by paralysis of multiple cranial nerves, and most often the abducens and facial nerves. Signs and symptoms of Moebius include paralysis of the facial muscles, swallowing and choking problems, crossed eyes, bone abnormalities in the hands, speech difficulties, high or cleft palate, excessive drooling, and various others. As per the National Center for Advancing Translational Sciences, abnormality of the voice, masklike facies, Bell's palsy, feeding difficulties in infancy, and open mouth commonly occur in 80%-99% cases of Moebius syndrome.
According to the U.S National Library of Medicine, Moebius syndrome affects 1 in 50,000 to 1 in 500,000 newborns. It also mentions that the affected individuals lack facial expressions i.e. they cannot smile, or raise their eyebrows.
It is noted that growing public awareness and technological advancements are the key factors driving the Moebius syndrome market. On the technology front, various surgical options have been used for an effective management of symptoms associated with Moebius syndrome such as facial nerve grafting, facial nerve decompression, transposition of the temporalis muscle, and others.
Various other factors such as unmet medical needs, increasing government assistance, rising healthcare expenditure in the developed countries, improving regulatory framework, increasing adoption rate, and rising funding and reimbursement policies are continuously contributing to the growth of the Moebius syndrome market. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and the hospital care accounted for a share of 32.3%.
Despite these drivers, there are some issues associated with Moebius syndrome market. The complications associated with the available treatments, infections, and injuries caused by surgical devices, and poor healthcare system in low and middle-income countries, may hinder the growth of the Moebius Syndrome Market.
It is estimated that the Moebius syndrome market is expected to grow at a CAGR of 6.5% during the forecast period of 2017-2023.
Key Players
Some of key the players in the moebius syndrome market are Alcon Laboratories, Inc, All Vascular, Pty Ltd., Aspen Surgical Products, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Conmed Corporation, Gray Surgical, Johnson & Johnson Services, Inc., Medtronic, Olympus Corporation, Smith & Nephew plc, TransEnterix Surgical, Inc., Zimmer Biomet Holdings, Inc., and others.
Intended Audience
- Medical Device Companies
- Research and Development (R&D) Companies
- Diagnostic Laboratories
- Government Research Institute
- Academic Institutes and Universities
Research Methodology 
Sources: Annual reports, Press release, White paper, and Company presentation
Segmentation
The Moebius syndrome market is segmented on the basis of type, treatment, and end user.
On the basis of the type, the market is classified as Group I, Group II, Group III, and Group IV.
On the basis of the treatment, the market is classified as surgery, temporalis transfer, parotidectomy, physical therapy, occupational therapy, speech therapy, splints, prosthesis, braces, and others. The surgery segment is further classified into eyelid surgery, ponseti method, hand surgery, tracheotomy, and others.
On the basis of the end user, the market is segmented into medical device companies, hospitals & clinics, academic & research institutes, and others.
Regional Analysis
The Americas dominate the Moebius syndrome market owing to the rising awareness among the population coupled with and high healthcare expenditure.
Europe holds the second position in the Moebius syndrome market. It is expected that the support provided by the government authorities for research & development and initiatives taken to improve the reimbursement policies in healthcare is likely to drive the European market.
Asia Pacific is the fastest growing Moebius syndrome market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare, in the years 2015-2016, the total health expenditure in Australia was USD 170.4 billion, which is recorded to be 3.6% higher than the expenditure of 2014-2015.
The Middle East & Africa holds the lowest share of the market due to lack of technical knowledge and poor medical facilities.
Frequently Asked Questions (FAQ) :
moebius syndrome market is projected to grow at a 6.5% CAGR between 2017-2023.
The Americas is expected to dominate the moebius syndrome market.
Unmet medical needs and favorable reimbursement policies are the key factors driving the moebius syndrome market growth.
Poor healthcare system may limit the moebius syndrome market growth.
Major end users of the moebius syndrome market include academic and research institutes, hospitals and clinics, and medical device companies.
